Please assess the completion status of the following clinical trial:

Trial Title: Hyperbaric Oxygen for Wagner II Diabetic Lower Extremity Ulcers

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Age equal to or greater than 18.~2. Type 1 or 2 diabetes mellitus.~3. Wagner Grade 2 wound for at least 4 weeks. A diagnosis of a Wagner Grade 2 wound necessitates a persistent wound of 4 weeks (5).~4. DoD Beneficiary.~Exclusion Criteria:~1. Impending/urgent amputation due to ongoing or exacerbated infection.~2. Severe depression.~3. Claustrophobia.~4. Seizure disorder.~5. Uncontrolled asthma/severe COPD with pCO2 \> 45 mmHg on arterial blood gas.~6. Grade 4 congestive heart failure.~7. Unstable angina.~8. Chronic/acute otitis media/sinusitis.~9. Major tympanic membrane trauma.~10. Prior chemotherapy with Bleomycin and evidence of deterioration in diffusing capacity after a single hyperbaric oxygen exposure.~11. Candidates for vascular surgery/angioplasty/stenting or patients with major large vessel disease. These patients could have peripheral vascular disease of such severity that hyperbaric treatment would not improve their condition.~12. Vascular surgery/angioplasty within the last 3 months. This exclusion controls for improvements to a patients vasculature and perfusion that occur within 1-2 months after vascular surgery/angioplasty. This will ensure that any perfusion changes to the patient's diabetic wound ulcer area recorded during the study are a result of hyperbaric therapy instead of recent vascular procedures.~13. Women who are breast feeding or of childbearing potential.~14. Dementia or mental disability rendering the potential subject incapable of following instructions or consenting to treatment.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Standard treatment plus Hyperbaric Oxygen (Type: EXPERIMENTAL): The study treatment group will be compressed on air in the hyperbaric chamber to 2.0 atmospheres absolute (ATA), then placed on 100% oxygen by a head tent for 90 minutes.
- Standard treatment with Hyperbaric Room Air (Type: PLACEBO_COMPARATOR): The study control group will be compressed to 2.0 ATA on air, then breath 21% oxygen and 79% nitrogen through the hood for 90 minutes.

Based on this trial design, predict the completion outcome and termination type (if applicable).